Reta glucagon-like peptide-1 (GLP-1) receptor agonists provide a groundbreaking method to diabetes management. These innovative drugs operate by mimicking the physiological actions of GLP-1, a hormone produced by the https://matteononi787955.smblogsites.com/39108386/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes